What are you looking for?
Start main content

A simple tool to decrease recurrence of liver cancer



Hepatocellular carcinoma, the most common type of primary liver cancer, is the second most common cause of cancer-related death. Although surgical removal of the tumour is the most effective treatment, recurrence occurs in 30-50% of patients within 2 years. The large international study on the “Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection” developed statistical models that can predict the risk of early hepatocellular carcinoma recurrence after resection. Using an online calculator, the statistical model can help enhance patient counselling and design clinical trials for drugs that decrease the risk of recurrence (J Hepatol. 2018 Dec;69(6):1284-1293. doi: 10.1016/j.jhep.2018.08.027. Epub 2018 Sep 18).
Anyone interested in future collaboration in this field of research is welcome to contact our key investigator, Dr Anthony Chan of our Department of Anatomical and Cellular Pathology. Dr Chan is an expert in liver and gastrointestinal pathologies in both tumorous and non-tumorous diseases.
Read the full article:
More about research at CU Medicine: